Pathobiology
Original Paper
Enzymatic Modulation of the Cell Surface in Malignant Transformation of Normal Human Mammary Epithelial Cells and in Conversion of Mammary Carcinoma CellsHakim A.A.Departments of Surgery, Physiology and Biophysics, Oral Diagnosis, School of Medicine, University of Illinois at the Medical Center, Chicago, Ill.
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: September 14, 1978
Accepted: October 28, 1978
Published online: October 03, 2008
Issue release date: 1979
Number of Print Pages: 19
Number of Figures: 0
Number of Tables: 0
ISSN: 1015-2008 (Print)
eISSN: 1423-0291 (Online)
For additional information: https://www.karger.com/PAT
Abstract
The effect of treatment with trypsin and neuraminidase on morphology, proliferation pattern, adhesiveness and ultrastructure of human normal mammary and carcinoma cell lines has been investigated. These criteria were chosen because they reflect on the cell surface function. Active enzymes were required to produce changes. If trypsinized and then allowed to grow in culture media supplemented with ‘fibroblast growth-promoting factor’, human normal mammary epithelial cells proliferated in a disorganized pattern with cells overlapping and piling up and developing ultrastructural characteristics of neoplastic cells. On the other hand, if treated with neuraminidase and then permitted to grow in presence of the ‘fibroblast growth-promoting factor’, mammary carcinoma cells proliferated in an organized pattern, forming one-cell-thick, fibroblast-like monolayers and ultrastructural characteristics of normal epithelial cells.
© 1979 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Received: September 14, 1978
Accepted: October 28, 1978
Published online: October 03, 2008
Issue release date: 1979
Number of Print Pages: 19
Number of Figures: 0
Number of Tables: 0
ISSN: 1015-2008 (Print)
eISSN: 1423-0291 (Online)
For additional information: https://www.karger.com/PAT
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission